Name: Michael G. Stabin
Office Address: MCN S1312
Office Phone Number: 615-343-0068
Date and Place of Birth: Aug 29, 1957, Miami, FL
Education:



University of Florida, Gainesville, FL, B.S., Environmental Engineering - 1981
University of Florida, Gainesville, FL, M.E., Environmental Engineering (Health
Physics emphasis) - 1983
University of Tennessee, Knoxville, TN, Ph.D., Nuclear Engineering (Health
Physics emphasis) - 1996
Licensure and Certification:
Certified Health Physicist - 1988, Recertified - 1992, 1996, 2000, 2004.
Academic Appointments:



Assistant Professor, Department of Radiology and Radiological Sciences,
Vanderbilt University – 2000-pres.
Secondary Appointment, Department of Physics and Astronomy, Vanderbilt
University – 2000-pres.
Secondary Appointment, Department of Civil and Environmental Engineering,
Vanderbilt University – 2005-pres.
Employment:
Visiting Professor, Universidade Federal de Pernambuco, Recife, Brasil - 1998 - 2000.
Scientist, Radiation Internal Dose Information Center, Oak Ridge Associated
Universities, Oak Ridge, Tennessee - 1983 - 1998.
Student assistant and graduate assistant - Department of Environmental Engineering.
1980-1983.
Professional Organizations:
Health Physics Society
 President, Medical Section, 1993-1994 (first section president), President 20052006
 East Tennessee Chapter of the Health Physics Society
o Secretary (1989-1990)
o Council Member (1986)

o Chair of Public Education Committee (1983-1985)
o President-Elect (1998)
American Board of Health Physics, Part II Panel of Examiners, 2000-2005, chair
2004-2005.
Sigma Xi – President, Nashville Chapter, 2005-2007.
Tau Beta Pi, Member 1984-pres
Professional Activities:
Associate Editor, Health Physics Journal, 1992-present
Associate Editor, Journal of Nuclear Medicine, 1998-pres.
Editorial Board, Cancer Biotherapy & Radiopharmaceuticals, 1998- pres.
Society of Nuclear Medicine's Medical Internal Radiation Dose (MIRD) committee,
corresponding member – 2001-2004, full member 2004-2007.
Special Task Group of the International Commission on Radiological Protection on Dose
to Patients from Radiopharmaceuticals, corresponding member – 1991-2004, member
2004-present.
ICRP Committee 2 Task Group on Dose Calculations (DOCAL), corresponding member
- 2002 – present.
Human Subjects Radiation Committee and Radioactive Drug Research Committee,
Vanderbilt University, 2001-2004.
Radiation Safety Committee, Vanderbilt University, 2004-pres.
Conflict of Interest Committee, Vanderbilt University, 2005-pres.
Health Physics Society Electronic Media Committee, 2001 – pres.
Special Task Group of the American Association of Physicists in Medicine on dosimetry
for monoclonal antibodies - 1988 - present
Teaching Activities:



Radiology Residents – Department of Radiology and Radiological Sciences
short course, preparation for Physics sections of Board Examinations, 20012004
Graduate School Courses:
o PHY-243, Health Physics, Fall Semester, 2002 – pres
o PHY-285. Radiation Detection and Measurement. Spring Semester,
alternating years, 2003 – pres
o PHY-307, Advanced Health Physics. Spring Semester, alternating years,
2006 – pres. New course created and approved by Dept of Physics and
Astronomy 2005.
Continuing Medical Education: Frequent lecturer, Society of Nuclear
Medicine Continuing Education Sessions on Internal Dosimetry (CME
Credits given), 1987 – pres.
Research Supervision (residents or fellows, postdoctoral trainees,
graduate students, medical students): name(s), date(s), current position of
trainee







International Atomic Energy Agency, type II fellowship, Ms. Stella Veloza at the
Vanderbilt University, School of Medicine, Department of Radiology and
Radiological Sciences, Nashville, TN, USA, from 11 June to 10 August 2007.
Jucilene Pereira, PhD candidate, Universidade Federal de Pernambuco, Recife,
Brasil, assisting with research on resolution and detection limits in quantitative
data taken with nuclear medicine cameras for internal dose calculations, July
2006-pres.
Derek Favret, Vanderbilt University, Master’s student, Department of Physics and
Astronomy, 2004-2006. Subject – Analysis of Radiological Implications of a
Terrorist Attack on a Nuclear Reactor Spent Fuel Pool.
Laelia P. Campos, Master’s student, Departamento de Energia Nuclear, 19982000. Subject – calculation of radiation dose distributions in intravascular
brachytherapy. Result - received Master’s degree, two publications from thesis.
Eduardo Loureiro, PhD student, Departamento de Energia Nuclear, 1998- 2002.
Subject – adapt voxel-based images to the calculation of radiation doses from
diagnostic radiology in dentistry. Result - received PhD degree, one publication
from thesis.
Fabiana Farias da Lima, PhD student, Departamento de Energia Nuclear, 19982002. Subject – evaluate methods for patient-specific imaging and treatment
planning for thyroid cancer patient treatment. Result - received PhD degree, two
publications from thesis.
Helio Yoriyaz, CNEN-IPEN, Sao Paulo, Brazil, 1996-1997. Subject - investigate
ability of radiation transport software to perform patient-specific dosimetry.
Result – PhD awarded 1998.




Michalene Rodriguez, Colorado State University, 1996. Subject - develop kinetic
model for kinetics of iodine in subjects whose thyroids have been removed
surgically or with radioiodine. Result - received Master’s degree, completed
project report.
Joy Russell, University of Tennessee, 1995. Subject - use newly developed
pregnant female phantoms to calculate radiation dose estimates at all stages of
pregnancy for many radiopharmaceuticals. Result - received Master’s degree,
completed thesis, received student award from Health Physics Society, two full
articles published in Health Physics Journal, 1997.
Julie Behm, Master’s student, University of Florida, 1994. Supervised on several
projects involving new models for internal dosimetry. Also served on advisory
committee for Master’s degree. Result - received Master’s degree, completed
thesis.
David Marshall, Master’s student, University of Texas, 1993. Subject development of phantom representing woman at 6 months’ pregnancy. Result received Master’s degree, completed thesis, thesis became part of publication of
ORNL report on 4 phantoms representing the adult female at different stages of
pregnancy.
Other Significant Activities:
MIRDOSE and OLINDA/EXM Software
I developed and wrote the MIRDOSE software package, which has been distributed to
over 2000 sites worldwide. It automates the calculation of internal dose estimates,
primarily in nuclear medicine. The OLINDA/EXM code was written with collaborators at
CDE, Inc. in Knoxville, TN and is designed to replace the MIRDOSE code. It was
granted permission for marketing as a 510(k) device by the FDA in 2004.
Radsafe Professional Mailing List
When the Radsafe mailing list, which has about 2000 members worldwide and posts 1050 e-mail messages per day on the topic of radiation protection, was moved from the
University of Illinois at Urbana – Champaign campus, I had it moved to the Vanderbilt
campus and took over as list owner/manager. In 2005, it was moved to another site.
Civic Activities
Volunteer, Nashville Rescue Mission – 2001-2002
Volunteer, Vanderbilt Pediatric Emergency Department – 2002-2003
PENCIL Foundation, Choices program, Nashville Public Schools, 2004-2005
Research Program:
1) New Methods for Improved Image-Based Dosimetry, 5R01 CA104907-03 (Stabin)
09/01/2004-08/31/2007
2) Virtual Patients for Computing Radiation Doses, 5R01 CA116743-02/Rensselaer
Polytechnic Institute (Xu, Stabin as Vanderbilt PI)
09/01/2005-05/31/2008
3) Realistic Phantoms Series for OLINDA/EXM, 4R42 CA115122-02 (STTR Phase I-II)
(Stabin)
04/01/06-03/31/08
4) Consortium for Risk Evaluation with Stakeholder Participation III (CRESP III). DEFC01-06EW07053 (Kosson/Powers)
09/30/2006-09/29/2007
Publications and Presentations:
Complete Books
1) Radiation Protection and Dosimetry. Springer, proofs finished, due date August 2007.
2) Clinical Nuclear Medicine Dosimetry. Springer, proofs stage, due date Dercember
2007.
3) Fetal Dose Assessment – Standard Methods. Health Physics Society and American
National Standards Institute, in press 2006.
Book Chapters
1) Coffey JL, Watson EE, Hubner KF and Stabin MG. Radiopharmaceutical Absorbed
Dose Considerations. Chapter 5 in Essentials of Nuclear Medicine Science. WB
Hladik, III, GB Saha, and KT Study, Eds. Baltimore, William and Wilkins, 1987.
2) Stabin MG. Patient Dose from Diagnostic and Therapeutic Radiopharmaceuticals.
Internal Radiation Dosimetry, Health Physics Society 1994 Summer School, Otto G.
Raabe, Editor, Chapter 16, pp 375-392, 1994.
3) Stabin MG. Internal Dosimetry in Pediatric Nuclear Medicine. In: Pediatric Nuclear
Medicine Chapter 26, 556-581, Springer-Verlag, New York, Publisher, 1995.
4) Treves S, Connolly L, O'Tuama L, Stabin MG, Paltiel H, Larar G and Swift P.
Pediatrics. In Principles of Nuclear Medicine, H Wagner, Jr., Z Szabo, and J
Buchanan, eds. WB Saunders, Philadelphia, PA, pp 1137-1170, 1995.
5) Bushberg JT and Stabin MG. Radiopharmaceutical Dosimetry. Edited by MP
Sandler, RE Colman, JA Patton, FJ TH Wackers, A Gottschalk and PB Hoffer. In:
Diagnostic Nuclear Medicine, Third Edition, Volume 1, Chapter 19:293-307, 1996.,
Williams & Wilkens, Publisher, 1996.
6) Stabin MG. Internal Radiation Dosimetry. Nuclear Medicine, Vol 1, Chapter 25, 316333, edited by RE Henkin, MA Bales, GL Dillahay, JR Halema, SM Karesh, RH
Wagner, AM Zimmer. Published by Mosby, St. Louis, MO, 1996.
7) Stabin, M. and Zaidi, H. (2002) Monte Carlo codes for use in therapeutic nuclear
medicine. In Therapeutic applications of Monte Carlo calculations in nuclear
medicine. (Eds, Zaidi, H. and Sgouros, G.) Institute of Physics Publishing, London,
pp. 133-157.
8) Bouchet, L., Bolch, W., Stabin, M., Eckerman, K., Poston, J. W. and Brill, A. B.
(2002) Monte Carlo methods and mathematical models for the dosimetry of skeleton
and bone marrow. In Therapeutic applications of Monte Carlo calculations in nuclear
medicine. (Eds, Zaidi, H. and Sgouros, G.) Institute of Physics Publishing, London,
pp. 286-309.
9) Stabin, M. and Duggan, F. (2002) Monte Carlo modeling of dose distributions in
intravascular radiation therapy. In Therapeutic applications of Monte Carlo
calculations in nuclear medicine. (Eds, Zaidi, H. and Sgouros, G.) Institute of Physics
Publishing, London, pp. 310-323.
10) Stabin MG. Internal dose assessment – extrapolation from animal species to the
human. In: From Morphological Imaging to Molecular Targeting, Implications to
Preclinical Development. M. Schwaiger, L. Dinkelborg, H. Schweinfurth eds, Ernst
Schering Research Foundation Workshop 48, Springer, New York, pp 77-94, 2004.
11) Stabin MG. Dosimetric and radiobiologic considerations. In Nuclear Medicine in
Clinical Diagnosis and Treatment, PJ Ell and SS Gambhir, eds. Churchill
Livingstone, New York, 2004.
12) Stabin MG. Internal Radiation Dosimetry. Nuclear Medicine, 2nd Ed., Vol 1, Chapter
22, 313-331, edited by RE Henkin, MA Bales, GL Dillahay, JR Halema, SM Karesh,
RH Wagner, AM Zimmer. Published by Mosby, St. Louis, MO, 2006.
13) Stabin MG. Radiation Dosimetry Methods for Therapy. In Radionuclide Peptide
Cancer Therapy, Ch 13, pp 239-262, M Chinol and G Paganelli, eds. Taylor and
Francis, New York, NY, 2006.
14) Stabin MG. Internal Dosimetry. In Pediatric Nuclear Medicine/PET, S.T. Treves, ed.,
Springer, New York, NY, 2007.
Journal Articles
1) Cloutier RJ, Watson EE and Stabin MG. Applying the ICRP Risk Factors to Nuclear
Medicine Doses. Proceedings of Sixth Congress of the International Radiation
Protection Association Meeting, West Berlin. In: Compacts 1:497-500, 1984.
2) Watson EW and Stabin MG. BASIC Alternative Software Package for Internal Dose
Calculations. In: Computer Applications in Health Physics, Proceedings of the 17th
Midyear Topical Symposium of the Health Physics society, Pasco, WA, Feb 5-9,
1984, pp 7.79-7.86, 1984.
3) Marcus CS, Stabin MG, Watson EE and Kuperus JH. Contribution of Contaminant
In-114m/In-114 to In-111-Oxine Blood Dosimetry. J Nucl Med 26:1090-1093, 1985.
4) Marcus CS, Stabin MG and Watson EE. Pediatric Radiation Dose from [In-111]
Leukocytes. Letter to the Editor. J Nucl Med 27:1220-1221, 1986.
5) Brihaye C, Butler TA, Knapp FF, Jr., Guillaume M, Watson EE and Stabin MG. A
New Osmium-191/Iridium-191m Radionuclide Generator System Using Activated
Carbon. J Nucl Med 27:380-387, 1986.
6) Crook JE, Carlton JE, Stabin MG and Watson EE. Radiation Dose Estimates for
Copper-64 Citrate in Man. In: Proceedings of the Fourth International
Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, Oak Ridge Associated
Universities, CONF-851113--(DE86010102), 212-216, 1986.
7) Watson EE and Stabin MG. The Influence of Radioactive Contaminants on Absorbed
Dose Estimates for Radiopharmaceuticals. In: Proceedings of the Fourth International
Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN, Oak Ridge Associated
Universities, CONF-851113--(DE86010102), 331-345, 1986.
8) Watson EE, Stabin MG, Goodman MM, Knapp FF and Srivastava PC. A Comparison
of Radiation Dosimetry for Several Potential Myocardial Imaging Agents. In:
Proceedings of the Fourth International Radiopharmaceutical Dosimetry Symposium.
Oak Ridge, TN, Oak Ridge Associated Universities, CONF-851113--(DE86010102),
371-383, 1986.
9) Wiles HB, Lacy JL, Watson EE, Stabin MG et al. Radiation Dose Estimates for
Adults and Newborns from Tungsten-178 Based on Distribution Data in Adult and
Infant Animals. Proceedings of a Workshop on Age-Related Factors in Radionuclide
Metabolism and Dosimetry held in Angers, France, November 26-28, 1986, G.B.
Gerber, H. Metivier and H. Smith, eds., Boston, Martinus Nijhoff Publishers,
229-234, 1987.
10) Watson EE and Stabin MG. A Mathematical Model of the Nine-Month Pregnant
Woman for Calculating Specific Absorbed Fractions. Proceedings of a Workshop on
Age-Related Factors in Radionuclide Metabolism and Dosimetry held in Angers,
France, November 26-28, 1986, GB Gerber, H Metivier and H Smith, eds, Boston,
Martinus Nijhoff Publishers, 381-388, 1987.
11) Davis JL, Stabin MG, Cristy M and Ryman JC. Dosimetric Data for the Fetus
Derived from an Anatomical Model of Its Mother at the End of the First Trimester.
Proceedings of a Workshop on Age-Related Factors in Radionuclide Metabolism and
Dosimetry held in Angers, France, November 26-28, 1986, GB Gerber, H Metivier
and H Smith, eds, Boston, Martinus Nijhoff Publishers, 1987.
12) Marcus CS, Stabin MG, Watson EE et al. Dosimetry of Leukocytes Labeled with
Tc-99m-Albumin Colloid. Nuclear Medicine Communications 9:249-254, 1988.
13) Powers WJ, Stabin MG, Howse D, Eichling JO and Herscovitch P. Radiation
Absorbed Dose Estimates for Oxygen-15 Radiopharmaceuticals (H215O, C15O, O15O)
in Newborn Infants. J Nucl Med 29:1961-1970, 1988.
14) Lacy JL, Ball ME, Verani MS, Wiles HB, Babich JW, LeBlanc AD, Stabin MG,
Bolomey L and Roberts R. An Improved Tungsten-178/Tantalum-178 Generator
System for High Volume Clinical Applications. J Nucl Med 29:1526-1538, 1988.
15) Watson EE, Stabin MG, Davis JL and Eckerman KF. A Model of the Peritoneal
Cavity for Use in Internal Dosimetry. J Nucl Med 30:2002-2011, 1989.
16) Vallabhajola S, Zimmerman RE, Picard M, Stritzke P, Mena I, Stabin MG et al.
Technetium-99m ECD: A New Brain Imaging Agent: In Vivo Kinetics and
Biodistribution Studies in Normal Human Subjects. J Nucl Med 30:599-604, 1989.
17) Murphy PA, Beasley CW, Moore WH and Stabin MG. Thallium-201 in Human Milk:
Observations and Radiological Consequences. Health Physics 56(4):539-541, 1989.
18) Stabin MG. Radiation Dosimetry in Radionuclide Hysterosalpingography with
Tc-99m. J Nucl Med 30(3):415-416, 1989.
19) Siegel JA, Wessels BW, Watson EE, Stabin MG et al. Bone Marrow Dosimetry and
Toxicity for Radioimmunothrapy. Antibody, Immunoconjugates, and
Radiopharmaceuticals 3(4):213-233, Mary Ann Liebert, Inc, Publishers, 1990.
20) Watson EE, Stabin MG, Eckerman KF, Cristy M et al. Mathematical Models of the
Pregnant Woman at the End of the First and Third Trimester. In: Proceedings of the
Frontiers in Nuclear Medicine Joint Symposium on Dosimetry of Administered
Radionuclides, Washington, DC, September 21-22, 1989, pp 89-104, American
College of Nuclear Physicians, Washington, DC, 1990.
21) Stabin MG. Marrow Dose Calculation-Development and Practice. Antibody,
Immunoconjugates, and Radiopharmaceuticals 3(4):239-246, Mary Ann Liebert, Inc,
Publishers, 1990.
22) Stabin MG. Workshop on MIRD Technique. Proceedings of the Frontiers in Nuclear
Medicine Joint Symposium on Dosimetry of Administered Radionuclides,
Washington, DC, September 21-22, 1989, pp 156-166, American College of Nuclear
Physicians, Washington, DC, 1990.
23) RG Soundy, DA Tyrrell, RD Pickett and MG Stabin. The Radiation Dosimetry of
Tc-99m-Exametazime. Nuclear Medicine Communications 11:791-799, 1990.
24) Siegel, Jeffry A.; Wessels, Barry W; Watson, Evelyn E.; Stabin, Michael G.;
Vriesendorp, Huibert M.; Bradley, Eileen W.; Badger, Christopher C.; Brill, A.
Bertrand; Kwok, Cheuk S.; Stickney, Dwight R.; Eckerman, Keith F.; Fisher, Darrell
R.; Buchsbaum, Donald J.; and Order, Stanley E. Bone Marrow Dosimetry and
Toxicity for Radioimmunotherapy. Antibody, Immunoconjugates, and
Radiopharmaceuticals, 1990 Volume 3, No. 4, p 213-233.
25) Washburn LV, Sun TTH, Lee Y-CC, Byrd BL, Holloway EC, Crook JE, Stubbs JB,
Stabin MG, Brechbiel MW, Gansow OA and Steplewski Z. Comparison of Five
Bifunctional Chelate Techniques for Y-90 Labeled Monoclonal Antibody Co-17-1A.
Nucl Med Biol 18:313-321, 1991.
26) Stabin MG and Schlafke-Stelson AT. A List of Nuclear Medicine Radionuclides and
Potential Contaminants for Operators of in-vivo Counters. Health Physics
61(3):427-430, 1991.
27) Marshall DT, Stabin MG and Watson EE. Mathematical Phantom and Specific
Absorbed Fractions for the Adult Female at Six Months of Pregnancy. Presented at
Health Physics Society Annual Meeting, Washington, DC, July 21-26, 1991, Health
Physics 60(2):S9, 1991.
28) Stabin MG, Watson EE, Marcus CS and Salk R. Radiation Dosimetry for the Adult
Female and Fetus from I-131 Administration in Hyperthyroidism. J Nucl Med
32:808-813, 1991.
29) Stabin MG, Stubbs JB and Watson EE. Dosimetry of Swallowed Non-absorbed
Technetium-99m Radiopharmaceuticals in Paediatric Patients. Letter to the Editor in:
Eur J Nucl Med 18:288-289, 1991.
30) Thomas SR, Stabin MG, Chen CT and Samaratunga RC. MIRD Pamphlet No. 14: A
Dynamic Urinary Bladder Model for Radiation Dose Calculations. J Nucl Med
33(5):783-802, 1992.
31) Stabin MG, Taylor A Jr, Eshima D and Wooter W. Radiation Dosimetry for
Technetium-99m MAG3, Technetium-99m-DTPA, and Iodine-131-OIH Based on
Human Biodistribution Studies. J Nucl Med 33:33-40, 1992.
32) Stabin MG, Taylor A and Conway J. Radiation Dosimetry for Tc-99m MAG-3 in
Adults and Children. Proceedings of Fifth International Radiopharmaceutical
Dosimetry Symposium, Oak Ridge, TN, May 7-10, 1991, pp 434-443, 1992.
33) Stabin MG. Prediction of Radiation Dose to the GI Tract from Analysis of Blood and
Liver Time-Activity Curves. Proceedings of the Fifth International
Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, May 7-10, 1991, pp
202-218, 1992.
34) Stubbs JB, Smith GT, Stabin MG et al. An Approach to Cellular Level Dosimetry
Using Compartmental Model Analysis and Dynamic PET. Proceedings of the Fifth
International Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, May
7-10, 1991, pp 385-395, 1992.
35) Stabin MG and Watson EE. An Alternative to Convolution Integrals for Radiation
Absorbed Dose Calculations. Proceedings of the Fifth International
Radiopharmaceutical Dosimetry Symposium, Oak Ridge, TN, May 7-10, 1991, pp
457-466, 1992.
36) Mozley PD, Stubbs JB, Kung HF, Selikson MH, Stabin MG, Alavi A. Biodistribution
and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine
receptor. J Nucl Med. 34(11):1910-1917, 1993.
37) Watson EE, Stabin MG and Siegel J. MIRD Formulation. Med Phys 20(2), Pt 2, 511514, 1993.
38) Stabin MG, Stubbs JB and Watson EE. Recent Controversy in Radiation Dosimetry.
Editorial. Eur J Nucl Med 20(5):371-372, 1993.
39) Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laruelle M, Altikriti MS, Sybirska EH,
Malison RT, Neumeyer JL, Milius RA, Wang S, Stabin MG, Smith EO, Charney DS,
Hoffer PB and Innis RB. Evaluation of the monoamine uptake site ligand I-123
methyl 3-(4-iodophenyl)- tropane-2-carboxylate I-123 -CIT in nonhuman
primates: pharmacokinetics, biodistribution, and SPECT brain imaging coregistered
with MIR. Nucl Med Biol - Int J Rad App B 20:597-606, 1993.
40) Eary JF, Collins C, Stabin MG et al. Samarium-153-EDTMP Biodistribution and
Dosimetry Estimation. J Nucl Med 34(7):1031-1036, 1993.
41) Stabin MG. Radiation Dose to the Upper Spine from Therapeutic Administrations of
I-131 Sodium Iodide. J Nucl Med 34:695-696, 1993.
42) Stabin MG, Watson EE and Feld T. MIRDOSE 3 - The PC and MAC-Based Program
for MIRD Calculations in Adults, Children, and Pregnant Women. Presented at
Health Physics Society Annual Meeting, Atlanta, GA 7/11-15, 1993.
43) Verhoeff NPLG, Buseman Sokole E, Stabin MG et al. Dosimetry of Iodine-123
Iodobenzamide in Healthy Volunteers. Eur J of Nucl Med 20(9):747--752, 1993.
44) Siegel JA and Stabin MG. Absorbed Fractions for Electrons and Beta Particles in
Spheres of Various Sizes. J Nucl Med 35:152-156, 1994.
45) Stabin MG. Wall Dose Estimates. Letter to the Editor. J Nucl Med 35(1):190, 1994.
46) Stabin MG. Samarium-153-EDTMP Dosimetry. Letter to the Editor. J Nucl Med
35(1):191-192, 1994.
47) Stabin MG. A Model of the Prostate Gland for Use in Internal Dosimetry. J Nucl Med
35(3):516-520, 1994.
48) Stabin MG, Hamm RN, Turner JE & Bolch WE. Track Structure Simulation and
Determination of Product Yields in the Electron Radiolysis of Water Containing
Various Solutes. Radiation Protection Dosimetry 52(1-4):255-258, 1994.
49) Seibyl JP, Wallace E, Smith EO, Stabin MG, Baldwin RM, Zoghbi S, Zea-Ponce Y,
Gao Y, Zhang WY, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB & Innis RB.
Whole-Body Biodistribution, Radiation Absorbed Dose and Brain SPECT Imaging
with Iodine-123--CIT in Healthy Human Subjects. J Nucl Med 35(5):764-770,
1994.
50) Watson EE, Stabin MG & Stubbs JB. Dosimetry of Technetium-94m-Teboroxime.
Letter to the Editor. J Nucl Med 35(5):925-926, 1994.
51) Stabin MG, Eckerman KF, Ryman JC & Williams LE. Bremsstrahlung Radiation
Dose in Yttrium-90 Therapy Applications. J Nucl Med 35(8):1377-1380, 1994.
52) Evans JE, Stabin MG and Stubbs JB. Specific Absorbed Fractions of Energy from
Internal Photon Sources in Brain Tumor and Cerebrospinal Fluid. Med Phys
22(3):331-340, 1995.
53) Johnson TK and Stabin MG. Fast Acquisition for Technetium-99m Sestamibi
SPECT. Letter to the Editor. J Nucl Med 36(9):1723-1724, 1995.
54) KL Miller, L Perri, RC Christersen. GG Eichholz, ZR Glaser, RE Gonad, RV
Griffith, RF Holub, Y Horowitz, TE Hui, NE Ipe, KJ Kearfott, CA Little, CW Miller,
DW Miller, KL Nelson, MP Nunno, MT Ryan, AG Scott, SL Simon, CS Sims, MG
Stabin, G Stevenson, et al, editors. 1995. Centennial Issue of Health Physics Journal
69(5), ISSN 0017-9078, Williams & Wilkins, 867 pages, 1995.
55) Kearfott K and Stabin MG. Medical Uses of Radiation - The First 100 Years in
Review. Guest Editorial. Health Physics 69(5):609, 1995.
56) Rohe RC, Thomas SR, Stabin MG, Deutsch EA, Gerson MC, Cummings DD and
Maxon III, HR. Biokinetics and Dosimetry Analysis in Healthy Volunteers for a
Two-Injection (Rest-Stress) Protocol of the Myocardial Perfusion Imaging Agent
Technetium 99m-Labeled Q3. J Nucl Cardiol 2(5):395-404, 1995.
57) Stabin MG. MIRDOSE: Personal Computer Software for Internal Dose Assessment
in Nuclear Medicine. J Nucl Med 37(3):538-546, 1996.
58) Zuckier LS, Stabin MG, Krynyckyi BR, Zanzonico P and Binkert B. Effect of Prior
Radiopharmaceutical Administration on Schilling Test Performance: Analysis and
Recommendations. J Nucl Med 37(12):1995-1999, 1996.
59) Johnston RE, Mukherji SK, Perry JR & Stabin MG. Radiation Dose from
Breastfeeding Following Administration of Thallium-201. J Nucl Med 37:2079-2082,
1996.
60) Russell J, Stabin M and Sparks R. Placental Transfer of Radiopharmaceuticals and
Dosimetry in Pregnancy. Health Phys 73(5):747-755, 1997.
61) Stabin MG, Stubbs JB and Russell JR. Review of the Fetal Radiation Doses Received
from Fe-59 Kinetic Studies at Vanderbilt University in the 1940's. Health Phys
72(5):1-7, 1997.
62) Russell JR and Stabin MG, Sparks RB and Watson EE. Radiation Absorbed Dose to
the Embryo/Fetus from Radiopharmaceuticals. Health Phys 73(5):756-769, 1997.
63) Wan-Yu Lin, Chih-Phoon Lin, Si-Jung Yeh, Bor-Tsung Hsieh, Zei-Tsan Tsai, Gann
Ting, Tzu-Chen Yen, Shyh-Jen Wang, Furn F. Knapp, Jr and MG Stabin. Rhenium188 Hydroxyethylidene diphosphonate: a New Generator-Produced Radiotherapeutic
Drug of Potential Value for the Treatment of Bone Metastases. European J of Nucl
Med 24(6):590-595, June 1997.
64) Stabin MG. Deposition, Retention and Dosimetry of Inhaled Radioactive Substances.
Book Review of NCRP Report No. 125. J Rad Res 148(4):403-404, 1997.
65) Stabin M, Kooij PPM, Bakker WH, Inoue T, Endo K, Coveney J, de Jone R and
Minegishi A. Radiation Dosimetry for Indium-111-Penetreotide. J Nucl Med
38:1919-1922, 1997.
66) Stabin MG. Health Concerns Related to Radiation Exposure of the Female Nuclear
Medicine Patient. Presented at the International Conference on Radiation and Health,
Beer Sheva, Israel, Nov 1996. Env Health Perspect 105(Suppl 6):1403-1409, 1997.
67) N Iznaga-Escobar, LA Torres, A Morales, M Ramos, I Alvarez, N Perez, R Fraxedas,
O Rodriguez, N Rodrigues, R Perez, A Lage & MG Stabin. Technetium-99m-Labeled
Anti-EGF-Receptor Antibody in Patients with Tumor of Epithelial Origin: I.
Biodistribution and Dosimetry for Radioimmunotherapy. J Nucl Med 39(1 ):15-23,
1998.
68) Hamm RN, Turner JE and Stabin MG. Monte Carlo Simulation of Diffusion and
Reaction in Water Radiolysis - A Study of Reactant Jump Through and Jump
Distances. Radiat Environ Biophys 36;229-234, 1998.
69) Kotzerke J, Fenchel S, Guhlmann A, Stabin M, Rentschler M, Knapp F, Jr, and Reske
S. Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral
administration of perchlorate: Option for subsequent care after the use of liquid 188Re
in a balloon catheter. Nucl. Med. Comm. 19:795-801, 1998.
70) Stubbs JB, Evans JF and Stabin MG. Radiation Absorbed Doses to the Walls of
Hollow Organs. J Nucl Med 39 (11):1989-1995, 1998.
71) Stabin MG. Patient dose from diagnostic and therapeutic radiopharmaceuticals. In
Procedure Perative di Misura e Valutazioni Dosimetriche nelle Attività Sanitarie, Atti
del Corso - Convegno, San Miniato, 10-12 June, 1998. Pacini Editore, Pisa, 1998.
72) Stabin MG. Reply to “MIRDOSE 3.1 gives erroneous results under windows NT” J
Nucl Med. 1998 May;39(5):927.
73) Stabin MG and Gelfand MJ. Dosimetry of pediatric nuclear medicine procedures.
Quarterly Journal of Nuclear Medicine, 42(2):93-112, 1998.
74) Stabin MG and Evans J. The Radiation Dosimetry of Intrathecally Administered
Radionuclides using a New Model of the Spine and CSF. Presented at the Sixth
International Radiopharmaceutical Dosimetry Symposium held May 7-10, 1996 in
Gatlinburg, TN; Oak Ridge Associated Universities, 1999, A. Stelson, M. Stabin, R.
Sparks eds, pp 500-512.
75) Sparks R and Stabin M. Fetal radiation dose estimates for 131I sodium iodide in cases
where accidental conception occurs after administration. Presented at the Sixth
International Radiopharmaceutical Dosimetry Symposium held May 7-10, 1996 in
Gatlinburg, TN; Oak Ridge Associated Universities, 1999, A. Stelson, M. Stabin, R.
Sparks eds, pp 500-512.
76) Toohey RE and Stabin MG. Comparative Analysis of Dosimetry Parameters for
Nuclear Medicine. Presented at the Sixth International Radiopharmaceutical
Dosimetry Symposium held May 7-10, 1996 in Gatlinburg, TN; Oak Ridge
Associated Universities, 1999, A. Stelson, M. Stabin, R. Sparks eds, pp 532-551.
77) Russell J and Stabin M. Placental Transfer of Radiopharmaceuticals and Dosimetry in
Pregnancy. Presented at the Sixth International Radiopharmaceutical Dosimetry
Symposium held May 7-10, 1996 in Gatlinburg, TN; Oak Ridge Associated
Universities, 1999, A. Stelson, M. Stabin, R. Sparks eds, pp 679-704.
78) Stabin MG and Sparks RB. Some Issues in the Use of the Remainder of the Body
Correction. Presented at the Sixth International Radiopharmaceutical Dosimetry
Symposium held May 7-10, 1996 in Gatlinburg, TN; Oak Ridge Associated
Universities, 1999, A. Stelson, M. Stabin, R. Sparks eds, pp 440-445.
79) M. Cremonesi, M. Ferrari, M. Chinol, M. Stabin, C. Grana, G. Prisco, C. Robertson,
G. Tosi, G. Paganelli. Three-step radioimmunotherapy with yttrium-90 biotin:
dosimetry and pharmacokinetics in cancer patients. Eur J Nucl Med 26(2):110-120,
1999.
80) S.J. Kennel, M. Stabin, H. Yoriyaz, M. Brechbiel, S. Mirzadeh. Treatment of lung
tumor colonies with 90Y targeted to blood vessels: comparison with the -particle
emitter 213Bi. Nuclear Medicine & Biology 26:149-157, 1999.
81) Behr TM, Behe M, Stabin MG, et al. High-linear energy transfer (LET) alpha versus
low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy
and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A fab' fragments in a
human colonic cancer model. Cancer Res 1999 Jun 1;59(11):2635-43.
82) Siegel J, Thomas S, Stubbs J, Stabin M, Hays M, Koral K, Robertson J, Howell R,
Wessels B, Fisher D, Weber D, Brill A. MIRD Pamphlet No 16 – Techniques for
Quantitative Radiopharmaceutical Biodistribution Data Acquisition and Analysis for
Use in Human Radiation Dose Estimates. J Nucl Med 40:37S-61S, 1999.
83) M. G. Stabin, M. Tagesson, S.R. Thomas, M. Ljungberg, S.E. Strand. Radiation
dosimetry in nuclear medicine. Applied Radiation and Isotopes 50:73-87, 1999.
84) Bergman, C. Pohl, R. Venkataramanan, G. Burckjart, M. Stabin, M. Barmada, J.
Griffin, N-K. Cheung. Intrathecal administration of an anti-ganglioside antibody
results in specific accumulation within meningeal neoplastic xenografts in nude rats.
J. Immunotherapy 22(2): 114-123, 1999.
85) M. Stabin. Update: Internal dosimetry in the use of radiopharmaceuticals in therapy:
science at a crossroads? Cancer Biotherapy and Radiopharmaceuticals 14(2):81-89,
1999.
86) S.J. Kennel, M. Stabin, J. Roeske, L. Foote, P. Lankford, M. Terzaghi-Howe, H.
Patterson, J. Barkenbus, D. Popp, S. Mirzadeh. Radiotoxicity of bismuth-213 bound
to membranes of monolayer and spheroid cultures of tumor cells. Radiation Research
151:244-256, 1999.
87) F.F. Knapp, Jr., S. Guhlke, A. Beets, W-Y Lin, M. Stabin, H. Amols, J. Weinberger.
Endovascular beta irradiation for prevention of restenosis using solution
radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Cardiovascular Radiation Medicine 1(1):86-97, 1999.
88) Thomas SR, Stabin MG, Chen CT and Samaratunga RC. MIRD Pamphlet No. 14,
Revised: A Dynamic Urinary Bladder Model for Radiation Dose Calculations. J Nucl
Med 40(4):102S-123S, 1999.
89) M. Cremonesi, M. Ferrari, S. Zoboli, M. Chinol, M. Stabin, F. Orsi, H. Maekce, E.
Jermann, C. Robertson, M. Fiorenza, G. Tosi, G. Paganelli. Biokinetics and
dosimetry in patients administered with 111In-DOTA-Tyr3-octreotide: implications
for internal radiotherapy with 90Y-DOTATOC. Eur J Nucl Med 26(8):877-886,
1999.
90) Davis, K. Glowienka, R. Boll, K. Deal, M. Brechbiel, M. Stabin, P. Bochsler, S.
Mirzadeh, S. Kennel. Comparison of 225Ac actinium chelates: tissue distribution and
radiotoxicity. Nucl Med & Biol 26:581-589, 1999.
91) Toohey RE, Stabin MG, Watson EE. The AAPM/RSNA physics tutorial for
residents. RadioGraphics 20:533-546, 2000.
92) Eckerman K and Stabin M. Electron absorbed fractions and dose conversion factors
for marrow and bone by skeletal regions. Health Phys. 78(2):199-214, 2000.
93) Stabin MG and Konijnenberg M. Re-evaluation of Absorbed Fractions for Photons
and Electrons in Small Spheres. J Nucl Med 41:149-160, 2000.
94) Traino AC, Martino FDi, Lazzeri M, Stabin MG. Influence of thyroid volume
reduction on calculated dose in radioiodine therapy of Graves'hyperthyroidism. Phys
Med Biol. 45:121-129, 2000.
95) Cremonesi M, Ferrari M, Chinol M, Bartolomei M, Stabin MG, Sacco E, Fiorenza M,
Tosi G, Paganelli G. Dosimetry in radionuclide therapies with 90Y-conjugates: the
IEO experience. Q J Nucl Med 2000 Dec;44(4):325-32.
96) M. Stabin and H. Breitz. Breast Milk Excretion Of Radiopharmaceuticals:
Mechanisms, Findings, And Radiation Dosimetry. Continuing Medical Education
Article, Journal of Nuclear Medicine, 41(5):863-873, 2000.
97) M. G. Stabin, M. Konijnenberg, F. F. Knapp, Jr., and R. H. Spencer. Monte Carlo
modeling of radiation dose distributions in intravascular radiation therapy. Medical
Physics 27(5):1086-1092, 2000.
98) Stephen J. Kennel; Lara L. Chappell; Kate Dadachova; Martin W. Brechbiel; Trish K.
Lankford; Ila A. Davis; Michael Stabin; Saed Mirzadeh Evaluation of 225 Ac for
Vascular Targeted Radioimmunotherapy of Lung Tumors Cancer Biotherapy and
Radiopharmaceuticals 15(3): 235-244, 2000
99) F. DiMartino, A.C. Traino, M.G. Stabin, et al. A mathematical model of thyroid mass
reduction after radioiodine therapy of Graves’ disease. Physica Medica, 16(3):127136, July-Sept 2000.
100)
H. Yoriyaz, M. G. Stabin, and A. dos Santos. Monte Carlo MCNP-4B-based
absorbed dose distribution estimates for patient-specific dosimetry. J Nucl Med
42(4):662-669, 2001.
101) M. Stabin. Invited Commentary: Investigation of patient release criteria. J. Nucl.
Med. 42(6):916, 2001.
102) M. G. Stabin, J. A. Siegel, R. B. Sparks, K. F. Eckerman, and H. B. Breitz
Contribution to Red Marrow Absorbed Dose from Total Body Activity: A
Correction to the MIRD Method J. Nucl. Med. 42: 492-498, 2001.
103) Rodney J. Hicks, David Binns, and Michael G. Stabin. Pattern of Uptake and
Excretion of 18F-FDG in the Lactating Breast. J. Nucl. Med. 2001 42: 1238-1242.
104) M. G. Stabin, R. W. Howell, and N.C. Colas-Linhart. Modeling radiation dose and
effects from internal emitters in nuclear medicine: from the whole body to
individual cells. Cellular and Molecular Biology 47(3):535-544, 2001.
105) A. Amaral, N. Colas-Linhart, M. Stabin, A. Petiet, F. Guiraud-Vitaux, N. Jacquet.
In vitro irradiation of blood with 99mTc: evaluation of dose and chromosome
aberrations in irradiated lymphocytes. Cellular and Molecular Biology 47(3):545548, 2001.
106) M.G. Stabin and A.B. Brill. Monoclonal antibodies in the treatment of hematologic
malignancies: radiation dosimetry aspects. Current Pharmaceutical Biotechnology,
2:351-356, 2001.
107) Mardirossian, G., Tagesson, M., Blanco, P.,. Bouchet, L., Stabin, M., Yoriyaz, H.,
Baza, S., Ljungberg, M., Strand, S-E., Brill, A.B., 1999. A New Rectal Model for
Dosimetry Applications, J Nucl Med, 1999; 40: 1524-1531.
108) F.D. Martino; A.C. Traino; A.B. Brill; M.G. Stabin; M. Lazzeri. A theoretical
model for prescription of the patient-specific therapeutic activity for radioiodine
therapy of Graves' disease. Phys Med Biol 47(9):1493-1499, 2002
109) F.D. Martino; A.C. Traino; A.B. Brill; M.G. Stabin; M. Lazzeri A theoretical
model for prescription of the patient-specific therapeutic activity for radioiodine
therapy of Graves' disease. Phys Med Biol 47(9):1493-1499, 2002
110) Michael G. Stabin; Jeffry A. Siegel; Richard B. Sparks. Sensitivity of Model-Based
Calculations of Red Marrow Dosimetry to Changes in Patient-Specific Parameters.
Cancer Biotherapy and Radiopharmaceuticals. 17(5): 535-543, 2002
111) M.G. Stabin and H. Yoriyaz. Photon specific absorbed fractions calculated in the
trunk of an adult male voxel-based phantom. Health Phys. 82(1):21-44, 2002.
112) Marguerite T. Hays, Evelyn E. Watson, Stephen R. Thomas, and Michael Stabin.
MIRD Dose Estimate Report No. 19: Radiation Absorbed Dose Estimates from
18F-FDG. J Nucl Med 2002;43 210-214.
113) S.J. Kennel, S. Mirzadeh, W. C. Eckelman, T.A. Waldemann, K. Garmestani, A. T.
Yordanov, M. G. Stabin, M. W. Brechbiel. Vascular-targeted radioimmunotherapy
with the alpha-particle emitter 211At. Radiation Research 157:633-641, 2002.
114) Stabin MG, da Luz CQPL. New Decay Data For Internal and External Dose
Assessment, Health Phys. 83(4):471-475, 2002.
115) M.G. Stabin, K.F. Eckerman, W.E. Bolch, L.G. Bouchet, and P.W. Patton.
Evolution and Status of Bone and Marrow Dose Models Cancer Biotherapy and
Radiopharmaceuticals, 17(4):427-434, 2002.
116) Stabin M, Brill AB. Physics in Nuclear Medicine: A Year of Tangible Progress. J
Nucl Med 44(1):22N-24N, 2003.
117) Todd A. Riccobene, Renee C. Miceli, Clint Lincoln, Yvonne Knight, Joseph
Meadows, Michael G. Stabin and Cynthia Sung. Rapid and Specific Targeting of
125I-Labeled B Lymphocyte Stimulator to Lymphoid Tissues and B Cell Tumors in
Mice. J Nucl Med 2003; 44:422–433.
118) JA Siegel, D, Yeldell, DM Goldenberg, MG Stabin, RB Sparks, RM Sharkey, A
Brenner, RD Blumenthal. Red marrow radiation dose adjustment using plasma
FLT3-L cytokine levels: improved correlations between hematologic toxicity and
bone marrow dose for radioimmunotherapy patients. J Nucl Med 44:67-76, 2003.
119) Gregory A. Wiseman, Ellen Kornmehl, Bryan Leigh, William D. Erwin, Donald A.
Podoloff, Stewart Spies, Richard B. Sparks, Michael G. Stabin, Thomas Witzig,
and Christine A. White. Radiation Dosimetry Results and Safety Correlations from
90Y-Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed or Refractory NonHodgkin’s Lymphoma: Combined Data from 4 Clinical Trials. J Nucl Med 2003;
44:465–474.
120) Radiopharmaceutical Internal Dosimetry, Proceedings of the 2002 Nashville
Conference: Quantitative Imaging and Data Collection Methods. Guest Editors:
A.B. Brill and M.G. Stabin. Cancer Biotherapy and Radiopharmaceuticals, Volume
18 Number 1, page 59, February 2003, Volume 18 Number 2, page 179, Volume 18
Number 3, June 2003, page 379.
121) Gregory A. Wiseman; Bryan R. Leigh; William L. Dunn; Michael G. Stabin;
Christine A. White. Additional Radiation Absorbed Dose Estimates for Zevalin™
Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals, Volume 18
Number 2, pp 253-258. April 2003.
122) M. G. Stabin and J. A. Siegel. Physical Models and Dose Factors for Use in Internal
Dose Assessment. Health Physics, 85(3):294-310, 2003.
123) M.G. Stabin. Radiotherapy with internal emitters: what can dosimetrists offer?
Cancer Biotherapy and Radiopharmaceuticals 18(4):611-618, 2003.
124) M. G. Stabin. Developments in the internal dosimetry of radiopharmaceuticals.
Radiat. Prot. Dosim. 105(1-4):575-580 (2003).
125) Stabin M, Brill AB. Physics Applications in Nuclear Medicine: A Jump Ahead. J
Nucl Med 45(2):22N-24N, 2004.
126) Stabin M. Proposed addendum to previously published fetal dose estimate tables for
18F-FDG. J Nucl Med 45(4):634-635, 2004.
127) Lima, F.F.; Stabin, M.G.; Khoury, H.J. Volume and Activity Concentration
Estimation in Phantom of Thyroid Tissue Remnants Using SPECT. Radioprotecção
(2004) vol. 2 ( nº 4-5) pp. 44-53.
128) Barry W. Wessels, Wesley E. Bolch, Lionel G. Bouchet, Hazel B. Breitz, Gerald L.
DeNardo, Ruby F. Meredith, Michael G. Stabin, and George Sgouros. Bone
Marrow Dosimetry Using Blood-Based Models for Radiolabeled Antibody
Therapy: A Multiinstitutional Comparison. J Nucl Med 2004 45: 1725-1733.
129) Shi, C Y.; Xu, X G.; Stabin, M G. Specific Absorbed Fractions For Internal Photon
Emitters Calculated For A Tomographic Model Of A Pregnant Woman. Health
Phys. 87(5):507-511, 2004.
130) Thomas SR, Stabin MG, Castronovo FP. Radiation-absorbed dose from 201Tlthallous chloride. J Nucl Med. 46(3):502-508, 2005.
131) Stabin M and Brill AB. Physics Applications in Nuclear Medicine: Progress on
Many Fronts. J. Nucl. Med. 2005 46: 16N-22N.
132) Ramin V. Parsey, Marie-Jose Belanger, Gregory M. Sullivan, Norman R. Simpson,
Michael G. Stabin, Ronald Van Heertum, and J. John Mann. Biodistribution and
Radiation Dosimetry of 11C-WAY100,635 in Humans. J. Nucl. Med. 2005 46: 614-
619.
133) Michael G. Stabin, Richard B. Sparks, and Eric Crowe. OLINDA/EXM: The
Second-Generation Personal Computer Software for Internal Dose Assessment in
Nuclear Medicine. J Nucl Med 2005;46 1023-1027.
134) Jeffry A. Siegel, Richard B. Sparks, Robert M. Sharkey, Barry W. Wessels, Wesley
E. Bolch, Lionel G. Bouchet, Hazel B. Breitz, Ruby F. Meredith, George Sgouros,
and Michael G. Stabin. Blood-Based Red Marrow Dosimetry: Where’s the Beef? J.
Nucl. Med. 2005 46: 1404-1406.
135) B.M. Dantas, A.L.A. Dantas, F.L.N. Marques1, L. Bertelli and M.G. Stabin.
Determination of 99Mo contamination in nuclear medicine patient submitted to
diagnostic procedure with 99mTc. Brazilian Archives of Biology and Technology. v.
48. Special Issue: pp. 215-220. October 2005. ISSN 1516-8913.
136) Michael Stabin and A. B. Brill. Physics Applications in Nuclear Medicine:
Organization and Progress. J. Nucl. Med. 2006 47: 22N-27N
137) Hazel B. Breitz, MD; Richard E. Wendt III, PhD; Michael S. Stabin, PhD; Sui
Shen, PhD; William D. Erwin, MS; Joseph G. Rajendran, MD; Janet F. Eary, MD;
Lawrence Durack; Ebrahim Delpassand MD; William Martin, MD; and Ruby F.
Meredith, MD. 166Ho-DOTMP Radiation-Absorbed Dose Estimation for Skeletal
Targeted Radiotherapy. J Nucl Med 2006; 47:534–542.
138) Michael G. Stabin, Todd E. Peterson, George E. Holburn, and Mary A. Emmons.
Voxel-Based Mouse and Rat Models for Internal Dose Calculations. J. Nucl. Med.
2006 47: 655-659.
139) Andrew B. Newberg, Nancy A. Wintering, Karl Plossl, John Hochold, Michael G.
Stabin, Marianne Watson, Daniel Skovronsky, Christopher M. Clark, Mei-Ping
Kung, and Hank F. Kung. Safety, Biodistribution, and Dosimetry of 123I-IMPY: A
Novel Amyloid Plaque-Imaging Agent for the Diagnosis of Alzheimer's Disease. J
Nucl Med 2006;47 748-754.
140) Dominique Delbeke, R. Edward Coleman, Milton J. Guiberteau, Manuel L. Brown,
Henry D. Royal, Barry A. Siegel, David W. Townsend, Lincoln L. Berland, J.
Anthony Parker, Karl Hubner, Michael G. Stabin, George Zubal, Marc Kachelriess,
Valerie Cronin, and Scott Holbrook. Procedure Guideline for Tumor Imaging with
18
F-FDG PET/CT 1.0. J Nucl Med 2006;47 885-895.
141) Michael Stabin, Nuclear medicine dosimetry, Review article, Phys. Med. Biol. 51
(2006) R187–R202.
142) Seza A. Gulec, Geraldine Mesoloras, and Michael Stabin. Dosimetric Techniques in
90Y-Microsphere Therapy of Liver Cancer: The MIRD Equations for Dose
Calculations. J Nucl Med 2006;47 1209-1211.
143) J Willegaignon; Michael G. Stabin; Maria I. C. Guimarães; Luiz F. Malvestiti;
Marcelo T. Sapienza; Marília Maroni; Gian-Maria A. A. Sordi. Evaluation of the
potential absorbed doses from patients based on whole-body 131i clearance in
thyroid cancer therapy. Health Phys 91(2):123-125, 2006.
144) Brill AB, Stabin M, Bouville A, Ron E. Normal organ radiation dosimetry and
associated uncertainties in nuclear medicine, with emphasis on iodine-131.
Radiation Research 166(1), part 2:128-140, 2006.
145) Curtis C. Travis and Michael G. Stabin. 131I Ablation Treatment in Young Females
After the Chernobyl Accident. J Nucl Med 2006;47 1723-1727.
146) Tapan K. Nayak, Jeffrey P. Norenberg, Tamara L. Anderson, Eric R. Prossnitz,
Michael G. Stabin, Robert W. Atcher. Somatostatin-receptor-targeted -emitting
213Bi is therapeutically more effective than -emitting 177Lu in human pancreatic
adenocarcinoma cells. Nuclear Medicine and Biology 34 (2007) 185–193.
147) Joanna Burger; Michael Gochfeld; David Kosson; Charles W. Powers; Barry
Friedlander; Michael Stabin; Derek Favret; Stephen Jewett; Daniel Snigaroff;
Ronald Snigaroff; Tim Stamm; James Weston; Christian Jeitner; Conrad Volz.
Radionuclides In Marine Fishes And Birds From Amchitka And Kiska Islands In
The Aleutians: Establishing A Baseline. Health Physics: Volume 92(3) March 2007
pp 265-279.
Technical Reports
1) Roessler C, Stabin MG and Newell M. Radiation Studies - St. John's County
Borehole Mining Project Phase I. Progress Reports I through V and Final, 1981.
2) C.E. Roessler, G. S. Roessler, M. Stabin. Assessment of Potential Airborne
Radioactivity Emissions from a Proposed New Gypsum Disposal Field. Report to
Gardinier, Inc., 1982.
3) T. O'Meara, W. Marion, C. E. Roessler, G.S. Roessler, H. A. Van Rinsvelt, O. Myers,
M. Stabin, D. Gonzalez, E. Barreto, E. Perry. Environmental Contaminants in Birds:
Phosphate - Mine and Natural Wetlands. Report to the Florida Institute of Phosphate
Research, 1983.
4) Stabin MG. Radium-226 in Waterfowl Associated with Florida Phosphate Clay
Settling Areas. Master's Thesis, University of Florida, 1983.
5) Stabin M, Watson E, Cristy M, Ryman J, Eckerman K, Davis J, Marshall D and
Gehlen K. Mathematical Models and Specific Absorbed Fractions of Photon Energy
in the Nonpregnant Adult Female and at the End of Each Trimester of Pregnancy.
ORNL Report ORNL/TM-12907, 1995.
6) Stabin MG, Stubbs JB and Toohey RE. Radiation Dose Estimates for
Radiopharmaceuticals. NUREG/CR-6345, prepared for: US Nuclear Regulatory
Commission, US Department of Energy, US Department of Health & Human
Services, 81 pages, April 1996.
7) Stabin MG, Turner JE, Hamm RN and Klots CE. Stochastic Track-Structure
Simulation Methods and the Determination of Product Yields in the Radiolysis of
Water Containing Various Solutes. ORISE 97-0263, February 1997.
8) Powers CW, Burger J, Kosson D, Gochfeld M, Barnes D, Bliss L, Friedlander B,
Jewett S, Johnson M, Stabin M, Unsworth M, Volz C, Vyas V, Weston J. Amchitka
Independent Science Assessment: Biological and Geophysical Aspects of Potential
Radionuclide Exposure in the Amchitka Marine Environment. Consortium for Risk
Evaluation with Stakeholder Participation, II, Piscataway, NJ, 2005.
Presentations at Scientific Meetings:
Each year approximately 3-5 oral presentations and posters are given at the Society of
Nuclear Medicine meeting and 1 oral presentation is given at the Health Physics Society
meeting. Almost every year, one 2-hr professional enrichment training seminar and one
1-hr continuing education seminar is given by invitation at the Health Physics Society
meeting. In many years, invited continuing education seminars are given at the Society of
Nuclear Medicine meeting. In addition, invitations are received 3-5 times per year for
invited technical lectures and training courses by the international dosimetry community.
Some recent examples (not an exhaustive list):
 Invited lecturer, Methodological and Practical Issues in Internal Dosimetry,
Brescia, Italia 17 – 19 January 2008.
 Invited lecturer at the International Atomic Energy Agency's International
Conference on QA and New Techniques in Radiation Medicine (QANTRM),
Vienna, Austria, 13-15 November 2006.
 Invited participant, National Cancer Institute, mini-workshop on I-131 dosimetry
for the hyperthyroid patients, March 5, 2007.
 Invited lecture, Workshop on Internal Dosimetry Applied to the
Diagnostic/Therapeutic Use of Radiopharmaceuticals, October 2006, 16th – 20th,
Mendoza, Argentina, organized by the Autoridad Regulatoria Nuclear, Buenos
Aires, Argentina.
 Invited reviewer, United States Environmental Protection Agency, Office of
Research and Development, National Center dor Environmental Research, Peer
Review Panel Meeting for Health Physics, Washington, DC January 31, 2006.
 International Atomic Energy Agency, review current information on the possible
need for further international guidance on the formulation and application of
standards for the protection of pregnant workers and their embryos and fetuses, in


order to determine whether the issue warrants action at the international level,
IAEA headquarters in Vienna, November 21-25, 2005 and May 8-12, 2006
International Atomic Energy Agency Technical Co-operation Project COS/6/01601, Project: Strengthening Internal Dosimetry Programme in Metabolic
Radiotherapy, Task: Medical Physics - Internal Dosimetry, Duty Period: 24-28
May 2004, San José, Costa Rica.
Invited lecturer, Internal Dosimetry in Nuclear Medicine, 9 - 13 August 2004,
Buenos Aires , Argentina, organized by the Autoridad Regulatoria Nuclear,
Buenos Aires, Argentina.